О нас



# 2 (26) 2019




Training of specialists at the level

of international standards


LifeMed Holding


Our mission: Providing high-quality medical care to the population


The main thing now is to work without slowing down


Early Cancer Diagnosis saves lives


Drop of price in life

The main thing is to faithfully serve the people


We trust the health of the child

We educate professionals


Your health is in safe hand


We work for the benefit of your health


We bring good to people


We are giving the joy of motherhood


With Care & Compassion

There are no trifles in medicine


Your health is in reliable safety


LifeMed Holding


LifeMed Holding is a domestic company whose mission envisages the principle of serving for the benefit of people, for the good of our younger generation and for the good of the health of our Nation!

LLP LifeMed Holding was established in December 2014. The founder of the Company is Tolemisova Aray Magauiyanovna academician of the IAIN, doctor of medical sciences and professor who shares innovative projects for Kazakhstan.






A life worthy of its name – it is dedication to the good of others.

 B. Washington



The principal direction of the company's activity is pharmaceutical business along with the delivery, sales and distribution of medicines, hygiene products, medical devices and medical equipment. The company also provides the population with preventive (immunobiological, diagnostic and disinfectant) drugs and pharmaceutical services to ensure a guaranteed free medical care. LifeMed Holding LLP is a company registered

LifeMed Holding LLP is a company registered in accordance with the legislation of the Republic of Kazakhstan, which is engaged in wholesale distribution of medicines in accordance with the State License.

Today, the company cooperates with state medical organizations in 16 Regions of the Republic of Kazakhstan and private companies and medical centers.


LLP LifeMed Holding participates in the State Screening Program for the early detection of cancer pathologies of the women reproductive system (Cervical Cancer) in the regions of the Republic of Kazakhstan and supplies reagents to the apparatus of liquid cytology produced in South Korea.

The company is also the official distributor of Becton Dickinson International, USA in the Republic of Kazakhstan, which sells their products in three areas: oncology, microbiology and tuberculosis.

Since 2014, the company has been the sole distributor of a large Korean company Bioneer Corporation the manufacturer of molecular diagnostics.

Since 2017, it is the only distributor of the South Korean Corporation supplying nutrient media to the Kazakhstan market.

Owing to the Company’s engagement, for the first time in the Republic of Kazakhstan, the products to determine the sensitivity of Mycobacterium tuberculosis to first-line and second-line antibiotics were developed and introduced. It has significantly contributed to the early diagnosis of pulmonary infections and tuberculosis including multiple drug resistance and extreme drug resistance to tuberculosis and the onset of the specific treatment of patients according to their health state. This novelty allowed to replace two types of research with the use of equipment of two different manufacturers at a single-time one study based on Bioneer Corporation. It allowed to contribute to the support of the economy of our country, as well as the development of scientific medicine of the Republic of Kazakhstan.

Bioneer Company developed modern products and technologies for molecular biology, including oligonucleotides, thermostable polymerases and gene manipulation tools (automatic nucleic acid extractor, thermal cycler, real-time QPCR Instruments, and DNA sequencer). Since its inception, Bioneer has invested in the integration of recombinant DNA technology, fermentation, biochemistry and nucleic acid chemistry in addition to mechanics, photonics and electronics. The company is positioned to fully integrate its ability to develop next-generation technologies in the post-genome era through the invention of new biochemistry and tools. Today, Bioneer manages two manufacturing and research facilities in Korea.





Universal Molecular Diagnostic System


ExiStation™ is an automated real-time PCR based on a molecular diagnostic system for the detection of infectious diseases. This equipment allows to detect human immunodeficiency virus, hepatitis viruses, mycobacterium tuberculosis, sexually transmitted infections, pathogens of gastrointestinal infections, blood infections as well as human genotyping.






The partners of the Company include BECTON DICKINSON International the branch of Becton Dickinson B.V. Belgium which is an international manufacturer of medical equipment and medical products, whose principal business is the improvement of drug delivery systems and diagnostics of infectious and oncological diseases and support in the development of new medicines. BD develops, manufactures and sells medical devices, laboratory consumables, antibodies, reagents and diagnostic products through the Company's three main business units: BD Medical Systems, BD Diagnostic Systems, BD Biotechnology.

One of the main products of BEKTON DICKINSON International Manufacturer is a bacteriological analyzer BD Bactec™ MGIT™ 960. This is an automated modular system (3 sections) for Crop Testing & Control System intended for invitro mycobacteria diagnostics from clinical specimens: moisture, bronchial washings, pleural exudate, synovial and cerebral fluids and determine the sensitivity of mycobacteria to first-line drugs (streptomycin, isoniazid, rifampicin, ethambutol and pyrazinamide).

Furthermore, the Smears Preparing & Staining System for BD PrepStain™ Cytological Studies proved its demand in the market of medical equipment in Kazakhstan. The technological feature of this system is that the material under study is taken into a special preservation solution, which ensures its safety without destruction and loss of cells. At the same time, all cellular material is preserved, the cells do not change their morphological and immunocytochemical properties.

A very important advantage of BD PrepStain Reagents is the possibility of their use for molecular biological studies, such as the immunocytochemical detection of microorganisms in cervical smears. Immunocytochemical method allows to detect human papillomavirus in thin-layer specimen whose identification is of great importance in anti-cancer screening.

BD PrepStain is a universal system that can be used both for the preparation of cytological specimen in gynecology and for the study of other biological material.

As noted above, LifeMed Holding LLP takes part in the State Screening Program for the early detection of cancer pathologies (Cervical Cancer) of the women reproductive system by supplying the Cell Cyan 100A liquid cytology apparatus to medical organizations of our country.

Papanicolaou test for cervical cancer is a simple way to screen cancer cells with a macroscopic examination of the cervix. However, the accuracy of the results can be problematic, depending on the sampling method, location and reading ability, while the false negative result rate, which shows a negative result even in the presence of the disease is about 10-30%.

Liquid Cytology Test (Cell Scan100A) of LifeMed Holding is a test that complements the shortcomings of traditional cytology by creating a single-layer pallet that evenly distributes cells from the cervix. This reduces the field of view of the microscope, reduces errors in the reading process and makes it possible to get accurate readings with 100% efficiency without cytopathic changes. The Sell Scan 100A device allows you to see all the cells of a biological material, because they are evenly distributed on the pallet, and foreign materials are also removed by the device.






Today, the nutrient medium M-Kit, a product of the Tuberculosis Institute at the Korean Tuberculosis Association, South Korea, provides significant assistance in the specific diagnosis of tuberculosis and determination of the sensitivity of mucobacteria of tuberculosis to fist-line and second-line drugs.

At the beginning of 2019, the Company signed an Agreement with a well-known manufacturer of medical equipment in the field of ELISA, PCR diagnostics by FUJIREBIO EUROPE N.V. Corporation, which has more than 50 years of experience in developing IVD Testing Solutions.

The corporation is the world leader in the field of high-quality tests for Invitro Diagnosis (IVD). Historically originated in Japan with a deep-rooted culture of country excellence, Fujirebio over the years has been shaped by the successful integration of innovative and experienced international IVD players such as CentocorDiagnostics in 1998, CanAgDiagnostics in 2006, and Innogenetics in 2010. The Corporation’s global presence includes offices in the USA, Europe, Latin America and Asia, as well as it has an extensive international distribution network.

In addition to operational activities, the company provides sponsorship support to medical workers of our country to increase their professional training, as well as mastering modern methods of diagnosing and treating diseases both in Kazakhstan and in neighboring countries, especially in medical universities, medical clinics in concert with the manufacturers from the USA, South Korea, Belgium, Germany, France, India, Turkey, the Russian Federation.

The Company pays great attention to rendering charitable assistance. In particular, assistance was provided to KULYNSHAK Children's Charity Foundation, students from large families and children with disabilities.




Адрес редакции:


Республика Казахстан, 050026, г. Алматы,

ул. Кожамкулова, 16В


Тел.:      +7 (727)233 50 42


Моб.:     +7 702 765 20 00

                  +7 777 276 64 32


e-mail:  novaera01@bk.ru




Издается  с января 2014 г.

Зарегистрирован в Министерстве культуры и информации Республики Казахстан. Регистрационное свидетельство №15904-Ж от 25.03. 2016 г.

Собственник и издатель – ИП «Костина И.А.»

Отправка формы…

На сервере произошла ошибка.

Форма получена.

Отправка формы…

На сервере произошла ошибка.

Форма получена.